Anna Maria D'URSI | Projects
Anna Maria D'URSI Projects
18 Funded projects
Filter
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Finanziamenti da bandi nazionali Ministeriali ed altri EEPP | |
Funders | Università degli Studi di SALERNO MINISTERO DELLA SALUTE | |
Cost | 148.064,36 euro | |
Project duration | 1 January 2023 - 31 December 2030 | |
Detail |
⿢Collect, preparation and metabolomic analysis of SMNο7 mice tissue to outline the specific-organ role of SMN gene in SMA pathology⿢Collection and preparation of biofluids (serum, urine, saliva, faeces) from fibromyalgia patients before and after ketogenic or low glycaemic index diet (LOGI)⿢Use of bioinformatics and biostatistics approach for metabolomics data analysis ⿢Integration of metab
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 3.816,90 euro | |
Project duration | 31 July 2023 - 31 July 2026 | |
Detail |
Active
Alzheimer's disease (AD), is the most common neurodegenerative disorder of the aging population resulting in progressive cognitive and functional decline. Accumulation of amyloid plaques around neuronal cells is considered a critical pathogenetic event and, in most cases, a hallmark of the pathology. In the attempt to identify anti-AD drug candidates, hundreds of molecules targeting Aß peptides ha
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 12.000,75 euro | |
Project duration | 25 July 2022 - 25 July 2025 | |
Detail |
Consulenza Analitico/Scientifica per la caratterizzazione di sostanze di interesse farmaceutico di natura peptidica
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Third Party Activities - Research | |
Funders | FRESENIUS KABI IPSUM SRL | |
Cost | 35.000,00 euro | |
Project duration | 5 February 2024 - 31 December 2024 | |
Detail |
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 13.450,17 euro | |
Project duration | 15 February 2021 - 15 February 2024 | |
Detail |
Concluded
CONSULENZA ANALITICO/SCIENTIFICA SIU SOSTANZE DI INTERESSE FARMACEUTICO DI NATURA PEPTIDICA
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Third Party Activities - Research | |
Funders | FRESENIUS KABI IPSUM SRL | |
Cost | 58.000,00 euro | |
Project duration | 20 March 2023 - 30 June 2023 | |
Detail |
Mesenchymal stem cells (MSCs) are endowed with huge regenerating potential. [3, 4] According to the International Society for Cellular Therapy (ISCT), they must show adherence to plastic in standard culture conditions. They have to express specific surface markers (= 95%), that are CD105, CD73 and CD90 and at the same time they must lack expression (= 2%) of CD45, CD34, CD14 or CD11b, CD79a or CD1
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 18.288,21 euro | |
Project duration | 18 May 2020 - 18 May 2023 | |
Detail |
Studio analitico/scientifico per la caratterizzazione di sostanze di interesse farmaceutico di natura peptidica
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Third Party Activities - Research | |
Funders | FRESENIUS KABI IPSUM SRL | |
Cost | 35.000,00 euro | |
Project duration | 1 February 2022 - 31 December 2022 | |
Detail |
In the perspective of a theranostic application, the present project is focused on the identification of new substances able to detect Aß peptide at minimal concentration, to be used for early AD diagnosis and to control the formation of ß amyloid fibrils to be used in AD therapy.The project will be developed according to the following points:Identification of Aß-interacting molecules starting
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 12.017,69 euro | |
Project duration | 11 March 2019 - 10 March 2022 | |
Detail |
Caratterizzazione del prodotto Salmon Calcitonin attraverso la tecnologia NMR - NMR Characterization of Salmon Calcitonin
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Third Party Activities - Research | |
Funders | FRESENIUS KABI IPSUM SRL | |
Cost | 11.100,00 euro | |
Project duration | 18 November 2021 - 31 December 2021 | |
Detail |
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Funds from other research activities | |
Funders | Tissue click LTD | |
Cost | 40.796,86 euro | |
Project duration | 29 June 2020 - 28 June 2021 | |
Detail |
Objective of the present project is the design of moleules able to catch potential neurodegenerative biomarkers. Ultimately, these will be used to functionalize ultra¿small Magnetic Nanoparticles (MNPs) for the early and ultrasensitive realization of a diagnostic device based on magnetoresistive sensors, microfluidic device,
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 13.134,49 euro | |
Project duration | 20 November 2017 - 20 November 2020 | |
Proroga | 20 febbraio 2021 | |
Detail |
Fondi di Finanziamento Attività Base Ricerca 2017 art. 1 commi 295 e ss. , L. 11 Dicembre 2016 n. 232
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Finanziamenti da bandi nazionali Ministeriali ed altri EEPP | |
Funders | MIUR - MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA' E DELLA RICERCA | |
Cost | 3.000,00 euro | |
Project duration | 1 January 2018 - 31 December 2019 | |
Detail |
Concluded
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Responsabile finanziario) | |
Funding | Funds from other research activities | |
Funders | Instruct Academic Services Limited | |
Cost | 10.000,00 euro | |
Project duration | 1 February 2017 - 31 January 2019 | |
Detail |
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 9.892,20 euro | |
Project duration | 29 July 2016 - 20 September 2018 | |
Detail |
ESECUZIONE DI ATTIVITA' DI RICERCA " SUPPORTO ANALITICO/SCIENTIFCO SU SOSTANZE DI INTERESSE FARMACEUTICO" - RESP. D'URSI
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Responsabile finanziario) | |
Funding | Third Party Activities - Research | |
Funders | FRESENIUS KABI IPSUM SRL | |
Cost | 35.000,00 euro | |
Project duration | 26 October 2016 - 31 October 2017 | |
Detail |
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 10.623,13 euro | |
Project duration | 11 December 2013 - 31 December 2016 | |
Detail |
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 11.627,16 euro | |
Project duration | 7 November 2014 - 6 November 2016 | |
Detail |
Data source U-GOV dal 1 Gennaio 2013